237 related articles for article (PubMed ID: 27317874)
1. RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization.
Li XQ; Lu JT; Tan CC; Wang QS; Feng YM
Cancer Lett; 2016 Sep; 380(1):78-86. PubMed ID: 27317874
[TBL] [Abstract][Full Text] [Related]
2. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
4. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
[TBL] [Abstract][Full Text] [Related]
5. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
[TBL] [Abstract][Full Text] [Related]
6. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
[TBL] [Abstract][Full Text] [Related]
7. Runx2 induces bone osteolysis by transcriptional suppression of TSSC1.
Wang DC; Wang HF; Yuan ZN
Biochem Biophys Res Commun; 2013 Sep; 438(4):635-9. PubMed ID: 23933319
[TBL] [Abstract][Full Text] [Related]
8. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
9. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
10. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
Pantano F; Croset M; Driouch K; Bednarz-Knoll N; Iuliani M; Ribelli G; Bonnelye E; Wikman H; Geraci S; Bonin F; Simonetti S; Vincenzi B; Hong SS; Sousa S; Pantel K; Tonini G; Santini D; Clézardin P
Oncogene; 2021 Feb; 40(7):1284-1299. PubMed ID: 33420367
[TBL] [Abstract][Full Text] [Related]
11. Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.
Tandon M; Chen Z; Othman AH; Pratap J
Oncogene; 2016 Sep; 35(36):4730-40. PubMed ID: 26804175
[TBL] [Abstract][Full Text] [Related]
12. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
13. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
14. Role of Runx2 in breast cancer-mediated bone metastasis.
Vishal M; Swetha R; Thejaswini G; Arumugam B; Selvamurugan N
Int J Biol Macromol; 2017 Jun; 99():608-614. PubMed ID: 28268169
[TBL] [Abstract][Full Text] [Related]
15. Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility.
Leong DT; Lim J; Goh X; Pratap J; Pereira BP; Kwok HS; Nathan SS; Dobson JR; Lian JB; Ito Y; Voorhoeve PM; Stein GS; Salto-Tellez M; Cool SM; van Wijnen AJ
Breast Cancer Res; 2010; 12(5):R89. PubMed ID: 21029421
[TBL] [Abstract][Full Text] [Related]
16. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicle-Packaged CDH11 and ITGA5 Induce the Premetastatic Niche for Bone Colonization of Breast Cancer Cells.
Li XQ; Zhang R; Lu H; Yue XM; Huang YF
Cancer Res; 2022 Apr; 82(8):1560-1574. PubMed ID: 35149589
[TBL] [Abstract][Full Text] [Related]
18. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
19. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.
Huang C; Verhulst S; Shen Y; Bu Y; Cao Y; He Y; Wang Y; Huang D; Cai C; Rao K; Liao DF; Jin J; Cao D
Oncotarget; 2016 Jul; 7(28):43779-43791. PubMed ID: 27248472
[TBL] [Abstract][Full Text] [Related]
20. A role for Runx2 in normal mammary gland and breast cancer bone metastasis.
Shore P
J Cell Biochem; 2005 Oct; 96(3):484-9. PubMed ID: 16052475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
